fromwww.theguardian.com1 week agoLawPurdue Pharma to be dissolved as judge approves criminal sentence in opioid case
fromFast Company2 weeks agoLawPurdue Pharma's sentencing in opioids case is imminent, clearing the way for settlement money to flow
fromABC7 Los Angeles2 weeks agoLawPurdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow
fromwww.mercurynews.com5 months agoPublic healthSan Mateo County to receive $3.3 million from Sackler family in opioid settlement
CannabisfromFortune10 months agoAll 50 states agree to OxyContin maker Purdue Pharma's plan for Sackler family to pay up to $7 billionLocal governments and victims are set to vote on a potential $7 billion settlement involving the Sackler family for opioid crisis accountability.
CannabisfromKqed10 months agoCalifornia to Get $440 Million in Nationwide Opioid Settlement With Purdue Pharma | KQEDPurdue Pharma's $7.4 billion settlement will support addiction treatment and require the Sackler family to relinquish control of the company.
Lawfromwww.theguardian.com1 week agoPurdue Pharma to be dissolved as judge approves criminal sentence in opioid casePurdue Pharma will be dissolved and replaced by a public good-focused company as part of a legal settlement addressing the opioid crisis.
LawfromFast Company2 weeks agoPurdue Pharma's sentencing in opioids case is imminent, clearing the way for settlement money to flowPurdue Pharma is set to forfeit $225 million to finalize a settlement over its role in the opioid crisis.
LawfromABC7 Los Angeles2 weeks agoPurdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flowPurdue Pharma is set to forfeit $225 million to finalize a settlement over its role in the opioid crisis.
fromwww.mercurynews.com5 months agoPublic healthSan Mateo County to receive $3.3 million from Sackler family in opioid settlement
fromFortune10 months agoCannabisAll 50 states agree to OxyContin maker Purdue Pharma's plan for Sackler family to pay up to $7 billion
fromKqed10 months agoCannabisCalifornia to Get $440 Million in Nationwide Opioid Settlement With Purdue Pharma | KQED
fromFast Company5 months agoPublic healthThe OxyContin settlement explained: Where the Sackler family's $7 billion will go
fromwww.aljazeera.com5 months agoPublic healthUS bankruptcy court to approve deal with Purdue Pharma and Sackler family
fromARTnews.com5 months agoArtsJudge Approves $7 B. Purdue Pharma Settlement, Potentially Ending Years-Long Legal Saga
fromwww.npr.org5 months agoPublic healthJudge says he'll approve opioid settlement with OxyContin maker Purdue and Sackler family
fromwww.theguardian.com5 months agoLawJudge to approve $7bn settlement with OxyContin maker that requires Sackler family members to pay victims
fromABC7 Los Angeles5 months agoPublic healthJudge says he'll approve opioid settlement with OxyContin maker Purdue and Sackler family
fromFast Company5 months agoPublic healthThe OxyContin settlement explained: Where the Sackler family's $7 billion will go
fromwww.aljazeera.com5 months agoPublic healthUS bankruptcy court to approve deal with Purdue Pharma and Sackler family
fromARTnews.com5 months agoArtsJudge Approves $7 B. Purdue Pharma Settlement, Potentially Ending Years-Long Legal Saga
fromwww.npr.org5 months agoPublic healthJudge says he'll approve opioid settlement with OxyContin maker Purdue and Sackler family
fromwww.theguardian.com5 months agoLawJudge to approve $7bn settlement with OxyContin maker that requires Sackler family members to pay victims
fromABC7 Los Angeles5 months agoPublic healthJudge says he'll approve opioid settlement with OxyContin maker Purdue and Sackler family
Public healthfromMission Local8 months agoS.F. to receive $8 to 12 million from opioid lawsuit payoutSan Francisco will receive $8 to $12 million from the nationwide Sackler-Purdue settlement addressing opioid marketing and resulting overdose harms.
Intellectual property lawfromPatently-O1 year agoThe Federal Circuit's Rigid Approach to Secondary ConsiderationsPurdue Pharma challenges the Federal Circuit's stringent 'nexus' requirement for evaluating patent non-obviousness in a Supreme Court appeal.
